Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
Molecular Weight | 662.7 g/mol |
---|---|
Molecular Formula | C28H43N6NaO9S |
Hydrogen Bond Donor Count | 7 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 17 |
Exact Mass | 662.27099243 g/mol |
Monoisotopic Mass | 662.27099243 g/mol |
Topological Polar Surface Area | 286 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1010 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 5 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A Imipenem And Cilastatin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imipenem And Cilastatin Sodium, including repackagers and relabelers. The FDA regulates Imipenem And Cilastatin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imipenem And Cilastatin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imipenem And Cilastatin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Imipenem And Cilastatin Sodium supplier is an individual or a company that provides Imipenem And Cilastatin Sodium active pharmaceutical ingredient (API) or Imipenem And Cilastatin Sodium finished formulations upon request. The Imipenem And Cilastatin Sodium suppliers may include Imipenem And Cilastatin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Imipenem And Cilastatin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Imipenem And Cilastatin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Imipenem And Cilastatin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Imipenem And Cilastatin Sodium DMFs exist exist since differing nations have different regulations, such as Imipenem And Cilastatin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Imipenem And Cilastatin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Imipenem And Cilastatin Sodium USDMF includes data on Imipenem And Cilastatin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Imipenem And Cilastatin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Imipenem And Cilastatin Sodium suppliers with USDMF on PharmaCompass.
Imipenem And Cilastatin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Imipenem And Cilastatin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Imipenem And Cilastatin Sodium GMP manufacturer or Imipenem And Cilastatin Sodium GMP API supplier for your needs.
A Imipenem And Cilastatin Sodium CoA (Certificate of Analysis) is a formal document that attests to Imipenem And Cilastatin Sodium's compliance with Imipenem And Cilastatin Sodium specifications and serves as a tool for batch-level quality control.
Imipenem And Cilastatin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Imipenem And Cilastatin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Imipenem And Cilastatin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Imipenem And Cilastatin Sodium EP), Imipenem And Cilastatin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Imipenem And Cilastatin Sodium USP).
LOOKING FOR A SUPPLIER?